PAXLOVID
PAXLOVID
Approved
DIN Number
02527804
Drug Class
Human
Market Date
Aug 1, 2022
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02527804
AIG Number0263338001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AE30 NIRMATRELVIR AND RITONAVIR
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.48
Health Canada Classification
ACTIVE INGREDIENTS (2)
NIRMATRELVIRActive
Strength: 150 MG
Monograph: NIRMATRELVIR
RITONAVIRActive
Strength: 100 MG
Monograph: RITONAVIR